{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:01:23Z","timestamp":1791907283676,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Neuroinflammation in the context of idiopathic normal pressure hydrocephalus (iNPH) is poorly studied. Currently, no single objective test can reliably predict outcomes after shunt surgery. The aim was to investigate whether neuroinflammatory proteins in cerebrospinal fluid (CSF) are associated with the characteristic symptoms of iNPH and whether they can predict outcome after shunting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Neuroinflammatory proteins were analyzed from preoperative CSF using proximity extension assay (PEA). In total, 92 proteins were analyzed from 74 patients with iNPH referred to shunt surgery at a single center, with follow-up at the same hospital. Symptoms were assessed before surgery and at follow-up (primarily 12 months post-surgery), graded with the Swedish iNPH scale. Associations between protein levels and preoperative symptoms, as well as outcome, were analyzed using linear regression models adjusted for age and sex; outcome models were additionally adjusted for baseline symptom level. Benjamini-Hochberg with a false discovery rate (FDR) of 5% was used to control for multiple analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 92 analyzed proteins, 60 had detectable values greater than 50% and were included in the analyses. No associations between preoperative symptom severity and levels of inflammatory proteins remained statistically significant after correction for multiple comparisons (FDR 5%). After adjustment, CST5 showed a significant negative association with postoperative improvement in balance and continence domains (b = -34, q\u2009=\u20090.017 and b = -35, q\u2009=\u20090.026, respectively) but not for outcome in the total iNPH scale. A general trend was observed where higher levels of inflammatory proteins were linked to less favourable outcomes, although these did not remain statistically significant after correction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CST5 emerged as the only protein significantly associated with postoperative improvement after shunt surgery, suggesting a potential role in iNPH pathophysiology. Furthermore, no associations were observed between preoperative symptom severity and levels of inflammatory CSF proteins.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-025-00751-9","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:46:46Z","timestamp":1767804406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inflammatory protein profiles and shunt response in iNPH"],"prefix":"10.1186","volume":"23","author":[{"given":"Madelene","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ekblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Freyhult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"\u00c5berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Nyholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Kultima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9901-2949","authenticated-orcid":false,"given":"Johan","family":"Virhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"1","key":"751_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02688697.2016.1229749","volume":"31","author":"N Sundstr\u00f6m","year":"2017","unstructured":"Sundstr\u00f6m N, Malm J, Laurell K, Lundin F, Kahlon B, Cesarini KG, et al. Incidence and outcome of surgery for adult hydrocephalus patients in Sweden. Br J Neurosurg. 2017;31(1):21\u20137.","journal-title":"Br J Neurosurg"},{"issue":"10","key":"751_CR2","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00701-013-1835-5","volume":"155","author":"AK Toma","year":"2013","unstructured":"Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins LD. Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus. Acta Neurochir. 2013;155(10):1977\u201380.","journal-title":"Acta Neurochir"},{"issue":"3","key":"751_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0404.2012.01676.x","volume":"126","author":"P Klinge","year":"2012","unstructured":"Klinge P, Hellstr\u00f6m P, Tans J, Wikkels\u00f8 C, On behalf of the European iNPH Multicentre Study Group. One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand. 2012;126(3):145\u201353.","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"751_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/archneur.1995.00540320059013","volume":"52","author":"J Malm","year":"1995","unstructured":"Malm J, Kristensen B, Karlsson T, Fagerlund M, Elfverson J, Ekstedt J. The predictive value of cerebrospinal fluid dynamic tests in patients with the idiopathic adult hydrocephalus syndrome. Arch Neurol. 1995;52(8):783\u20139.","journal-title":"Arch Neurol"},{"issue":"1","key":"751_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-8118-9-1","volume":"9","author":"M Ishikawa","year":"2012","unstructured":"Ishikawa M, Hashimoto M, Mori E, Kuwana N, Kazui H. The value of the cerebrospinal fluid tap test for predicting shunt effectiveness in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2012;9(1):1.","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"751_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","volume":"116","author":"A \u00c5gren-Wilsson","year":"2007","unstructured":"\u00c5gren-Wilsson A, Lekman A, Sj\u00f6berg W, Rosengren L, Blennow K, Bergenheim AT, et al. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand. 2007;116(5):333\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"751_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1743-8454-5-9","volume":"5","author":"M Tullberg","year":"2008","unstructured":"Tullberg M, Blennow K, M\u00e5nsson JE, Fredman P, Tisell M, Wikkels\u00f6 C. Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2008;5(1):9.","journal-title":"Fluids Barriers CNS"},{"issue":"12","key":"751_CR8","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00701-017-3314-x","volume":"159","author":"CL Craven","year":"2017","unstructured":"Craven CL, Baudracco I, Zetterberg H, Lunn MPT, Chapman MD, Lakdawala N, et al. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien). 2017;159(12):2293\u2013300.","journal-title":"Acta Neurochir (Wien)"},{"issue":"12","key":"751_CR9","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/cns.13526","volume":"26","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang Y, Hu F, Ding J, Wang X. Pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus. CNS Neurosci Ther. 2020;26(12):1230\u201340.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"751_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/01.WCB.0000093326.88757.49","volume":"24","author":"BK Owler","year":"2004","unstructured":"Owler BK, Momjian S, Czosnyka Z, Czosnyka M, P\u00e9na A, Harris NG, et al. Normal pressure hydrocephalus and cerebral blood flow: A PET study of baseline values. J Cereb Blood Flow Metab. 2004;24(1):17\u201323.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"751_CR11","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1093\/brain\/awx191","volume":"140","author":"G Ringstad","year":"2017","unstructured":"Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. 2017;140(10):2691\u2013705.","journal-title":"Brain"},{"issue":"5","key":"751_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/nan.12420","volume":"44","author":"PK Eide","year":"2018","unstructured":"Eide PK, Hansson H-A. Astrogliosis and impaired aquaporin\u20104 and dystrophin systems in idiopathic normal pressure hydrocephalus. Neuropathology Appl Neurobio. 2018;44(5):474\u201390.","journal-title":"Neuropathology Appl Neurobio"},{"key":"751_CR13","doi-asserted-by":"publisher","first-page":"8834822","DOI":"10.1155\/2021\/8834822","volume":"2021","author":"SD Lolansen","year":"2021","unstructured":"Lolansen SD, Rostgaard N, Oernbo EK, Juhler M, Simonsen AH, MacAulay N. Inflammatory markers in cerebrospinal fluid from patients with hydrocephalus: A systematic literature review. Dis Markers. 2021;2021:8834822.","journal-title":"Dis Markers"},{"issue":"4","key":"751_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5114\/fn.2017.72389","volume":"55","author":"K Czubowicz","year":"2017","unstructured":"Czubowicz K, G\u0142owacki M, Fersten E, Koz\u0142owska E, Strosznajder RP, Czernicki Z. Levels of selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in patients with hydrocephalus. Fn. 2017;55(4):301\u20137.","journal-title":"Fn"},{"issue":"15","key":"751_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","volume":"80","author":"A Jeppsson","year":"2013","unstructured":"Jeppsson A, Zetterberg H, Blennow K, Wikkels\u00f8 C. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers. Neurology. 2013;80(15):1385\u201392.","journal-title":"Neurology"},{"issue":"1","key":"751_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12987-021-00289-6","volume":"18","author":"SD Lolansen","year":"2021","unstructured":"Lolansen SD, Rostgaard N, Andreassen SN, Simonsen AH, Juhler M, Hasselbalch SG, et al. Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus. Fluids Barriers CNS. 2021;18(1):54.","journal-title":"Fluids Barriers CNS"},{"key":"751_CR17","doi-asserted-by":"crossref","unstructured":"Kamalian A, Barough SS, Ho SG, Albert M, Luciano MG, Yasar S et al. Molecular signatures of normal pressure hydrocephalus: a largescale proteomic analysis of cerebrospinal fluid. BioRxiv. 2024;2024.03.01.583014.","DOI":"10.1101\/2024.03.01.583014"},{"key":"751_CR18","first-page":"564","volume":"36","author":"L Sosvorova","year":"2015","unstructured":"Sosvorova L, Kanceva R, Vcelak J, Kancheva L, Mohapl M, Starka L, et al. The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus. Neuro Endocrinol Lett. 2015;36:564\u201371.","journal-title":"Neuro Endocrinol Lett"},{"issue":"Suppl 2","key":"751_CR19","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.33549\/physiolres.933069","volume":"64","author":"L Sosvorova","year":"2015","unstructured":"Sosvorova L, Mohapl M, Vcelak J, Hill M, Vitku J, Hampl R. The impact of selected cytokines in the follow-up of normal pressure hydrocephalus. Physiol Res. 2015;64(Suppl 2):S283\u2013290.","journal-title":"Physiol Res"},{"issue":"7","key":"751_CR20","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s00701-022-05154-5","volume":"164","author":"SG Thavarajasingam","year":"2022","unstructured":"Thavarajasingam SG, El-Khatib M, Vemulapalli KV, Iradukunda HAS, Laleye J, Russo S, et al. Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir. 2022;164(7):1719\u201346.","journal-title":"Acta Neurochir"},{"issue":"suppl3","key":"751_CR21","first-page":"S2","volume":"57","author":"N Relkin","year":"2005","unstructured":"Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PML. Diagnosing idiopathic Normal-pressure hydrocephalus. Neurosurgery. 2005;57(suppl3):S2\u20134.","journal-title":"Neurosurgery"},{"issue":"1","key":"751_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12987-022-00306-2","volume":"19","author":"M Braun","year":"2022","unstructured":"Braun M, Bjurnemark C, Seo W, Freyhult E, Nyholm D, Niemel\u00e4 V, et al. Higher levels of neurofilament light chain and total Tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus. Fluids Barriers CNS. 2022;19(1):15.","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"751_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0404.2012.01677.x","volume":"126","author":"P Hellstr\u00f6m","year":"2012","unstructured":"Hellstr\u00f6m P, Klinge P, Tans J, Wikkels\u00f8 C. A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand. 2012;126(4):229\u201337.","journal-title":"Acta Neurol Scand"},{"key":"751_CR24","doi-asserted-by":"crossref","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bj\u00f6rkesten J, Bucht Thorsen S, Ekman D et al. Homogenous 96-plex pea immunoassay exhibiting high sensitivity, specificity, and excellent scalability. Hoheisel JD, editor. PLoS ONE. 2014;9(4):e95192.","DOI":"10.1371\/journal.pone.0095192"},{"key":"751_CR25","doi-asserted-by":"publisher","first-page":"531777","DOI":"10.3389\/fgene.2020.00654","volume":"11","author":"F Maleki","year":"2020","unstructured":"Maleki F, Ovens K, Hogan DJ, Kusalik AJ. Gene set analysis: Challenges, Opportunities, and future research. Front Genet. 2020;11:531777.","journal-title":"Front Genet"},{"issue":"22","key":"751_CR26","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.3390\/cancers15225363","volume":"15","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhan F. Type 2 cystatins and their roles in the regulation of human immune response and cancer progression. Cancers. 2023;15(22):5363.","journal-title":"Cancers"},{"key":"751_CR27","doi-asserted-by":"crossref","unstructured":"Hill LJ, Di Pietro V, Hazeldine J, Davies D, Toman E, Logan A et al. Cystatin D (CST5): an ultra-early inflammatory biomarker of traumatic brain injury. Sci Rep 2017 July 10;7(1):5002.","DOI":"10.1038\/s41598-017-04722-5"},{"key":"751_CR28","doi-asserted-by":"crossref","unstructured":"Gao H, Zhang Z, Deng J, Song Y, Cathepsin S. Molecular mechanisms in inflammatory and immunological processes. Front Immunol 2025 July 7;16:1600206.","DOI":"10.3389\/fimmu.2025.1600206"},{"key":"751_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation \u2013 A target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"751_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1152\/physrev.00045.2017","volume":"99","author":"C Dostert","year":"2019","unstructured":"Dostert C, Grusdat M, Letellier E, Brenner D. The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiol Rev. 2019;99(1):115\u201360.","journal-title":"Physiol Rev"},{"issue":"7","key":"751_CR31","first-page":"586","volume":"35","author":"L Sosvorova","year":"2014","unstructured":"Sosvorova L, Vcelak J, Mohapl M, Vitku J, Bicikova M, Hampl R. Selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus. Neuro Endocrinol Lett. 2014;35(7):586\u201393.","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"751_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00253-020-11049-1","volume":"105","author":"P Wang","year":"2021","unstructured":"Wang P, Yang Y, Hong T, Zhu G. Proximity ligation assay: an ultrasensitive method for protein quantification and its applications in pathogen detection. Appl Microbiol Biotechnol. 2021;105(3):923\u201335.","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00751-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:16:25Z","timestamp":1781626585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-025-00751-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00751-9","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish National Ethical Review Authority (Dnr 2013\/278). Anonymized data that support the results of this study are available upon reasonable request to the corresponding author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}